Added to YB: 2021-04-10
Pitch date: 2021-04-10
FBRX:US [bullish]
Forte Biosciences, Inc.
-97.85%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata.
Market Cap
$76.7M
Pitch Price
$993.75
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.70
P/E
-0.65
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Forte Biosciences Inc. FBRX:US
A summary for this pitch has not been created yet.
Read full article (0 min)